Breaking News, Financial News

Financial Report: Kendle

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Kendle 4Q Revenues: $86.4 million (+64) 4Q Loss: $1.8 million (earnings were $5.2 million in 4Q2005) FY Revenues: $283.5 million (+40%) FY Earnings: $20.0 million (+16%) Comments: New business awards were $164 million in the quarter. For the year, total business authorizations, which consist of signed backlog and verbally awarded business, totaled a record $659 million. Loss in the quarter includes an $8.2 million impairment charge related to the August acquisition of the Phas...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters